Search Results 191-200 of 16196 for pharmacogenetics
Pegfilgrastim-jmdb injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...
Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...
This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...
Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily recognized as ...
Learn how genetic testing can help customize your cancer treatment plan. Precision medicine is improving breast cancer diagnosis, treatment and prevention.
About this study. The purpose of this research is to develop a better understanding of the cause of vascular overgrowth syndromes and to develop a ...
The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.
The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
About this study. Researchers would like to see if it is possible to predict which transplanted kidneys will do better long term based on the gene ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.